Please Wait.....
Report
Italy Drug Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-06-01 I 80 Pages I Mordor Intelligence
Italy Drug Delivery Devices Market Analysis
The Italy drug delivery devices market stood at USD 5.52 billion in 2025 and is forecast to reach USD 8.09 billion by 2030, reflecting a steady 7.96% CAGR. Growth is anchored in the country's rapidly aging population, the high and rising prevalence of chronic diseases such as diabetes and COPD, and a policy shift that favors self-administration over hospital-based care. Regulatory streamlining by the Italian Medicines Agency (AIFA) since January 2024 has shortened approval cycles for innovative products, while investment in connected technologies is improving adherence and real-time monitoring. At the same time, specialty pharmacies and community-based distribution models are extending access beyond large hospitals, accelerating uptake across the Italy drug delivery devices market.
Italy Drug Delivery Devices Market Trends and Insights
Growing Adoption of Pre-Filled Injectable Pens
Demand for shorter 4 mm needles and 32 G gauges is rising because they lessen tissue trauma and improve adherence, a priority underscored by national guidelines from the Italian Society of Metabolism and Obesity (SIMDO). Next-generation connected pens automatically log dose data and sync to smartphone apps, closing information gaps in diabetes care. However, uptake remains uneven due to limited provider training, leaving space for targeted education and value-demonstration programs.
Expansion of Specialty Pharmacies Boosting Biologic Self-Administration
Italy's decentralized distribution approach-direct hospital supply (DD), distribution on behalf of hospitals (DPC), and affiliated channels-has widened patient access to complex biologics outside tertiary centers. Analytics models piloted during the pandemic show potential to redirect a larger drug volume through community outlets, cutting travel time and hospital bottlenecks while maintaining cost control.
Slow Reimbursement Approval
Average reimbursement time for orphan products remains 413 days, far exceeding the 100-day statutory target and slowing roll-out of advanced drug delivery devices. Regional follow-through can add between 1 day and 773 days before products reach patients, creating pronounced territorial inequity.
Other drivers and restraints analyzed in the detailed report include:
Technological Advancement and Increasing Adoption of Smart and Connected Drug Delivery Devices / High Burden of Chronic Diseases and Aging Population / High Development and Manufacturing Cost /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Injectable formats generated 48.74% of Italy drug delivery devices market share in 2024 due to their established role in diabetes and autoimmune therapy regimens. Continuous refinement-such as 4 mm, 32 G insulin pen needles-improves tolerability and maintains the segment's broad user base. High-viscosity biologics are also benefiting from glass syringes engineered for superior break-resistance. In parallel, implantables are projected to post a 9.12% CAGR to 2030, marking the fastest trajectory within the Italy drug delivery devices market. Advances like 3-D printed polyvinyl alcohol matrices loaded with Rose Bengal enable sustained anticancer drug release for up to 90 days. Inhalation devices are pivoting to low-GWP propellants, while transdermal, ocular, and nasal platforms gain from novel polymers that extend residence time. Collectively, these innovations reinforce the long-term expansion of the Italy drug delivery devices market size at the modality level.
Injectables accounted for 61.22% of the Italy drug delivery devices market size in 2024, upheld by entrenched clinical protocols and the acceleration of automated insulin delivery systems that link pumps with continuous glucose monitors.Smart algorithms raise time-in-range and ease the burden of frequent dose decisions. Inhalation routes, expanding at a 8.64% CAGR, are propelled by triple combination pMDIs using the new HFA-152a propellant, which matches legacy efficacy while cutting global-warming potential by 90%. Transdermal, buccal, ocular, and nasal approaches are benefiting from micro-needle arrays and muco-adhesive gels that boost bioavailability yet face sterility and stability challenges.
Italy Drug Delivery Devices Market Report is Segmented by Device Type (Injectable Delivery Devices, Inhalation Delivery Devices, Infusion Pumps, and More), Route of Administration (Injectable, Inhalational, Transdermal Patches, Oral Mucosal and More), Application (Cancer, Cardiovascular, Diabetes and More), End User (Hospitals, Ambulatory Surgical Centers, and More). The Market and Forecasts are Provided in Terms of Value (USD).
List of Companies Covered in this Report:
Beckton Dickinson / Gerresheimer / Ypsomed / Nemera / Terumo / Pfizer / Novartis / Roche / Novo Nordisk / Baxter / Teva Pharmaceutical Industries / Insulet / Tandem Diabetes Care / West Pharmaceutical Services / AptarGroup Inc. / B. Braun / Owen Mumford / Elcam Medical /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing adoption of pre-filled injectable pens
4.2.2 Expansion of specialty pharmacies boosting biologic self-administration
4.2.3 Technological Advancement and Increasing Adoption of Smart and Connected Drug Delivery Devices
4.2.4 High Burden of Chronic Diseases and Aging Population
4.2.5 Expansion of Home-Care & Self-Administration
4.2.6 Supporting Reimbursement and Biosimilar Pen and Prefill Uptake
4.3 Market Restraints
4.3.1 Safety Concerns and Needlestick-injuries
4.3.2 Single-Use-Plastic Compliance Costs and Other Compliance Issues
4.3.3 High Development and Manufacturing Cost
4.3.4 Cultural Reluctance Toward Self-Injection Impacting Adherence
4.4 Value / Supply-Chain Analysis
4.5 Regulatory and Technological Outlook
4.6 Porter's Five Forces Analysis
4.6.1 Bargaining Power of Suppliers
4.6.2 Bargaining Power of Buyers
4.6.3 Threat of New Entrants
4.6.4 Threat of Substitutes
4.6.5 Intensity of Competitive Rivalry
5 Market Size and Growth Forecasts (Value-USD)
5.1 By Device Type
5.1.1 Injectable Delivery Devices
5.1.2 Inhalation Delivery Devices
5.1.3 Infusion Pumps
5.1.4 Transdermal Patches
5.1.5 Implantable Drug Delivery Systems
5.1.6 Ocular Inserts & Delivery Implants
5.1.7 Nasal & Buccal Delivery Devices
5.2 By Route of Administration
5.2.1 Injectable
5.2.2 Inhalation
5.2.3 Transdermal
5.2.4 Oral Mucosal (Buccal & Sublingual)
5.2.5 Ocular
5.2.6 Nasal
5.3 By Application
5.3.1 Cancer
5.3.2 Cardiovascular
5.3.3 Diabetes
5.3.4 Infectious Diseases
5.3.5 Other Applications
5.4 By End User
5.4.1 Hospitals
5.4.2 Ambulatory Surgical Centers
5.4.3 Home-care Settings
5.4.4 Other End Users
6 Competitive Landscape
6.1 Market Concentration
6.2 Strategic Moves
6.3 Market Share Analysis
6.4 Company profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
6.4.1 BD (Becton, Dickinson and Company)
6.4.2 Gerresheimer AG
6.4.3 Ypsomed AG
6.4.4 Nemera
6.4.5 Terumo Corporation
6.4.6 Pfizer Inc.
6.4.7 Novartis AG
6.4.8 F. Hoffmann-La Roche Ltd
6.4.9 Novo Nordisk A/S
6.4.10 Baxter International Inc.
6.4.11 Teva Pharmaceutical Industries Ltd
6.4.12 Insulet Corporation
6.4.13 Tandem Diabetes Care
6.4.14 West Pharmaceutical Services Inc.
6.4.15 AptarGroup Inc.
6.4.16 B. Braun Melsungen AG
6.4.17 Owen Mumford Ltd.
6.4.18 Elcam Medical
7 Market Opportunities and Future Outlook
7.1 White-Space and Unmet-Need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security